The GLP is committed to full transparency. Download and review our 2019 Annual Report

Bayer asks appellate court to toss $78 million glyphosate-cancer verdict

| | April 25, 2019
roundup monsanto bayer merger
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

Bayer AG on [April 24] asked a California appellate court to throw out a $78 million judgment it was ordered to pay to a school groundskeeper who claimed the company’s weed killers gave him cancer.

Related article:  Will Trump cut funding of UN agency accused of 'shoddy science’ for designating glyphosate probable carcinogen?

In a filing in California’s Court of Appeal, First Appellate District, the company said that there was “no evidence” that glyphosate, a chemical found in the company’s Roundup and Ranger Pro products, could cause cancer.

“Bayer stands behind these products and will continue to vigorously defend them,” the company said in a news release.

The widely-used weed killers are made by Monsanto, which Bayer acquired last year for $63 billion.

The company said that if the court did not rule in its favor, it should at least order a new trial, arguing that a lower court judge had improperly prevented jurors from hearing evidence that the U.S. Environmental Protection Agency and foreign regulators had deemed glyphosate not likely carcinogenic to humans.

Read full, original article: Bayer asks California appeals court to throw out $78 million Roundup verdict

News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend